| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 617 |
| 1 | LEFLUNOMIDE | 600 |
| 2 | ADALIMUMAB | 596 |
| 3 | TOCILIZUMAB | 595 |
| 4 | METHOTREXATE SODIUM | 593 |
| 5 | DICLOFENAC SODIUM | 578 |
| 6 | DICLOFENAC | 572 |
| 7 | ETANERCEPT | 572 |
| 8 | METHOTREXATE | 565 |
| 9 | SECUKINUMAB | 563 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEOMYCIN OINTMENT | 274 | 0.1191 |
| 1 | HYDROCORTISONE BUTYRATE | 166 | 0.0903 |
| 2 | DICLOFENAC POTASSIUM TABLETS | 458 | 0.0573 |
| 3 | TRIPROLIDINE HYDROCHLORIDE | 10 | 0.0568 |
| 4 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 28 | 0.0461 |
| 5 | DICLOFENAC POTASSIUM | 458 | 0.0443 |
| 6 | CAFFEINE CITRATE | 95 | 0.0435 |
| 7 | CORTISONE ACETATE | 445 | 0.0370 |
| 8 | PIROXICAM | 217 | 0.0346 |
| 9 | PSEUDOEPHEDRINE HYDROCHLORIDE | 313 | 0.0316 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 678 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 635 |
| 2 | Corticosteroid [EPC] | 627 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 627 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 626 |
| 5 | Antirheumatic Agent [EPC] | 600 |
| 6 | Vitamin C [EPC] | 588 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 565 |
| 8 | Vitamin B12 [EPC] | 564 |
| 9 | Interleukin-17A Antagonist [EPC] | 563 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 84 | 0.0088 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 146 | 0.0076 |
| 2 | Tetracycline-class Drug [EPC] | 450 | 0.0067 |
| 3 | Antirheumatic Agent [EPC] | 600 | 0.0058 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 627 | 0.0047 |
| 5 | Interleukin-12 Antagonist [EPC] | 474 | 0.0047 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 369 | 0.0046 |
| 7 | Aminosalicylate [EPC] | 555 | 0.0043 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 501 | 0.0037 |
| 9 | Methylxanthine [EPC] | 287 | 0.0032 |